| Product Name | MF | CAS | Details |
|---|
| Propylene Glycol Dicaprylate/Dicaprate (1 mL) | C21H44O6 | 68583-51-7 | Details |
| Propylene Glycol Dilaurate (500 mg) | C27H52O4 | 22788-19-8 | Details |
| Propylene Glycol Mono And Dicaprylate (1 g) | 85883-73-4 | Details |
| Propylene Glycol Monolaurate Type II (500 mg) | C15H32O4 | 37321-62-3 | Details |
| Propylthiouracil (200 mg) | C7H10N2OS | 51-52-5 | Details |
| Prostaglandin A1 (25 mg) | C20H32O4 | 14152-28-4 | Details |
| Prostaglandin B1 (25 mg) ((13E,15S)-15-Hydroxy-9-oxoprosta-8(12),13-dien-1-oic acid) | C20H32O4 | 13345-51-2 | Details |
| Protamine Sulfate (2.69 mg) | H2O4S | 9009-65-8 | Details |
| Protriptyline Hydrochloride (200 mg) | C19H22ClN | 1225-55-4 | Details |
| Pseudoisoeugenyl 2-Methylbutyrate (4 x 50 mg) ((E)-4-Methoxy-2-(prop-1-en-1-yl)phenyl 2-methylbutanoate) | C15H20O3 | 58989-20-1 | Details |
| Psoralen (10 mg) | C11H6O3 | 66-97-7 | Details |
| Punicalagin | C48H28O30 | 65995-63-3 | Details |
| Pygeum Extract (150 mg) | 94279-95-5 | Details |
| Pyrantel Pamoate (500 mg) | C34H30N2O6S | 22204-24-6 | Details |
| Pyrazinamide (200 mg) | C5H5N3O | 98-96-4 | Details |
| Pyrazinamide Related Compound B (50 mg) (Pyrazinecarbonitrile) | C5H3N3 | 19847-12-2 | Details |
| Pyridostigmine Bromide (200 mg) | C9H13BrN2O2 | 101-26-8 | Details |
| Pyridostigmine Related Compound B (10 mg) (3-Hydroxy-1-methylpyridin-1-ium bromide) | C6H8NO.Br | 31034-86-3 | Details |
| Pyridoxine Hydrochloride (200 mg) | C8H12ClNO3 | 58-56-0 | Details |
| Pyrilamine Maleate (200 mg) | C21H27N3O5 | 59-33-6 | Details |
| Pyrimethamine (200 mg) | C12H13ClN4 | 58-14-0 | Details |
| Pyrroloquinoline Quinone Disodium (100 mg) | C14H9N2NaO9 | 1519046-70-8 | Details |
| Quazepam Related Compound A (30 mg) (7-Chloro-5-(2-fluorophenyl)-1,3-dihydro-1-(2,2,2-trifluoroethyl)-2H-1,4-benzodiazepine-2-one) | C17H11ClF4N2O | 49606-44-2 | Details |
| Quercetin (200 mg) | C15H14O9 | 6151-25-3 | Details |
| Quetiapine Fumarate (200 mg) | C25H29N3O6S | 111974-72-2 | Details |
| Quinapril Related Compound B (50 mg) (3-Isoquinolinecarboxylic acid, 2-[2-[(1-carboxy-3-phenylpropyl)amino]-1-oxopropyl]-1,2,3,4-tetrahydro-,[3S-[2[R*(R*)],3R*]]) | C23H26N2O5 | 82768-85-2 | Details |
| Quinic Acid (200 mg) (Cyclohexanecarboxylic acid, 1,3,4,5-tetrahydroxy-, (-)-) | C7H12O6 | 77-95-2 | Details |
| Quinidine Gluconate (200 mg) | C26H36N2O9 | 7054-25-3 | Details |
| Quinine Sulfate (500 mg) | C40H52N4O9S | 207671-44-1 | Details |
| Quininone (50 mg) (Cinchonan-9-one, 6'-methoxy-, (8alpha)-) | C20H22N2O2 | 84-31-1 | Details |
| R,R-Lamivudine (25 mg) (4-amino-1-((2R,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one) | C8H11N3O3S | 139757-68-9 | Details |
| R-Levetiracetam Hydroxybutyramide Analog (10 mg) ((R)-N-(1-amino-1-oxobutan-2-yl)-4-hydroxybutanamide) | C8H16N2O3 | 1847568-87-9 | Details |
| Rabeprazole Sodium (250 mg) | Details |
| Racepinephrine Hydrochloride (100 mg) | C9H14ClNO3 | 329-63-5 | Details |
| Ractopamine Hydrochloride (200 mg) | C18H24ClNO3 | 90274-24-1 | Details |
| Raloxifene Hydrochloride (200 mg) | C28H28ClNO4S | 82640-04-8 | Details |
| Ramipril (125 mg) | C23H32N2O5 | 87333-19-5 | Details |
| Ranitidine Hydrochloride (200 mg) | C13H23ClN4O3S | 66357-59-3 | Details |
| Ranitidine Related Compound A (50 mg) (5-{[(2-Aminoethyl)thio]methyl}-N,N-dimethyl-2-furanmethanamine hemifumarate) | C13H22N4O3S | 256948-32-0 | Details |
| Raspberry Alcohol (50 mg) (4-(3-Hydroxybutyl)phenol) | C10H14O2 | 69617-84-1 | Details |
| Rauwolfia Serpentina (15 g) | 8063-17-0 | Details |
| Regular Bleached Shellac (100 mg) | unspecified | 9000-59-3 | Details |
| Regorafenib (200 mg) | C21H17ClF4N4O4 | 1019206-88-2 | Details |
| Repaglinide (200 mg) | C27H36N2O4 | 135062-02-1 | Details |
| Reserpine (200 mg) | C33H40N2O9 | 50-55-5 | Details |
| Residual Solvent Class 2 - Cyclopentyl Methyl Ether (1.2 mL/ampule; 3 ampules) | C6H12O | 5614-37-9 | Details |
| Risedronate Related Compound A (20 mg) ([1-Hydroxy-2-(2-pyridinyl)ethylidene]bis(phosphonic acid), monohydrate) | C7H13NO8P2 | 1220806-40-5 | Details |
| Risedronate Sodium (350 mg) | C7H14NNaO8P2 | 329003-65-8 | Details |
| Rivaroxaban Desmorpholinone Analog (25 mg) ((S)-5-chloro-N-((3-(4-((2-hydroxyethyl)amino)phenyl)-2-oxooxazolidin-5-yl)methyl)thiophene-2-carboxamide) | C17H18ClN3O4S | 936232-22-3 | Details |
| Rivaroxaban Open Ring Methylamine (10 mg) ((S)-4-(4-((2-hydroxy-3-(methylamino)propyl)amino)phenyl)morpholin-3-one) | C14H21N3O3 | 2459303-14-9 | Details |
| Rivaroxaban isomer (25 mg) (4-(4-(((2-(5-chlorothiophen-2-yl)-4,5-dihydrooxazol-5-yl)methyl)amino)phenyl)morpholin-3-one) | C18H18ClN3O3S | 2310316-95-9 | Details |
| Rivastigmine (0.1 mL) | C14H22N2O2 | 123441-03-2 | Details |
| Residual Solvent Class 2 - Sulfolane (1.2 mL/ampule; 3 ampules) | C4H8O2S | 126-33-0 | Details |
| Residual Solvent Class 2 - Tetralin (1.2 mL/ampule; 3 ampules) | C10H12 | 119-64-2 | Details |
| Retinyl Acetate (Vitamin A) (5 ampules x 0.5 g) | C22H32O2 | 127-47-9 | Details |
| Retinyl Palmitate (4 x 50 mg) | C36H60O2 | 79-81-2 | Details |
| Rhoifolin (15 mg) | C27H30O14 | 17306-46-6 | Details |
| Ribavirin (200 mg) | C8H12N4O5 | 36791-04-5 | Details |
| Ribavirin Related Compound D (15 mg) (1H-1,2,4-triazole-3-carboxamide) | C3H4N4O | 3641-08-5 | Details |
| Rifabutin (50 mg) | C46H62N4O11 | 72559-06-9 | Details |
| Rifampin (300 mg) | C43H58N4O12 | 13292-46-1 | Details |
| Rimexolone (100 mg) | C24H34O3 | 49697-38-3 | Details |
| Riociguat (250 mg) | C20H19FN8O2 | 625115-55-1 | Details |
| Rivastigmine Related Compound A (15 mg) ((+)-Di-(p-toluoyl)-D-tartaric acid) | C20H18O8 | 32634-68-7 | Details |
| Rizatriptan Benzoate (200 mg) | C22H25N5O2 | 145202-66-0 | Details |
| Roflumilast Related Compound C (50 mg) (3,5-Dichloropyridin-4-amine) | C5H4Cl2N2 | 22889-78-7 | Details |
| Ropinirole Related Compound B (50 mg) (4-[2-(Dipropylamino)ethyl]indoline-2,3-dione hydrochloride) | C16H23ClN2O2 | 221264-21-7 | Details |
| Rosavin (25 mg) ((2E)-3-Phenylprop-2-en-1-yl 6-O-alpha-l-arabinopyranosyl-Beta-D-glucopyranoside) | C20H28O10 | 84954-92-7 | Details |
| Rosiglitazone Related Compound A (25 mg) ((5Z)-5-{[4-({2-[methyl(2-pyridinyl)amino]ethyl}oxy)phenyl]methylidene}-1,3-thiazolidine-2,4-dione) | C18H17N3O3S | 160596-25-8 | Details |
| Rosmarinic Acid (25 mg) | C18H16O8 | 20283-92-5 | Details |
| Rotigotine Hydrochloride (300 mg) ((6S )-6-[Propyl(2-(2-thienyl)ethyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride) | C19H26ClNOS | 125572-93-2 | Details |
| Rotigotine Hydrochloride Ethyl Analog (25 mg) ((S)-6-(ethyl(2-(thiophen-2-yl)ethyl)amino)-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride) | 1369532-05-7 | Details |
| Rotigotine Racemate (25 mg) ((RS)-6-{Propyl[2-(thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride) | C19H26ClNOS | 102120-99-0 | Details |
| Rufinamide (200 mg) | C10H8F2N4O | 106308-44-5 | Details |
| Rufinamide Related Compound A (25 mg) (1-(2-Fluorobenzyl)-1H-1,2,3-triazole-4-carboxamide) | C10H9FN4O | 106308-41-2 | Details |
| Rufinamide Related Compound B (25 mg) (Methyl 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate) | C11H9F2N3O2 | 217448-86-7 | Details |
| Rutin (100 mg) | C27H30O163H2O | 250249-75-3 | Details |
| S-Allyl-L-Cysteine (25 mg) | C6H11NO2S | 21593-77-1 | Details |
| S-Levetiracetam Hydroxybutyramide Analog (10 mg) ((S)-N-(1-amino-1-oxobutan-2-yl)-4-hydroxybutanamide) | C8H16N2O3 | 1868118-63-1 | Details |
| Saccharin (200 mg) | C7H5NO3S | 81-07-2 | Details |
| Sevelamer Hydrochloride (100 mg) | C6H13Cl2NO | 152751-57-0 | Details |
| Sevoflurane (1 mL) | C4H3F7O | 28523-86-6 | Details |
| Sevoflurane Related Compound A (0.2 mL) (1,1,1,3,3-Pentafluoroisopropenyl fluoromethyl ether) | C4H2F6O | 58109-34-5 | Details |
| Saccharin Calcium (150 mg) | C7H7CaNO3S | 6485-34-3 | Details |
| Saccharin Sodium (200 mg) | C7H8NNaO4S | 6155-57-3 | Details |
| Safflower Oil (1 g) | NULL | 8001-23-8 | Details |
| Salvianolic Acid B (25 mg) | C36H30O16 | 121521-90-2 | Details |
| Saquinavir Mesylate (200 mg) | C39H54N6O8S | 149845-06-7 | Details |
| Schisandrin (15 mg) | C24H32O7 | 7432-28-2 | Details |
| Scopoletin (20 mg) | C10H8O4 | 92-61-5 | Details |
| Secoxyloganin (50 mg) ([(2S,3R,4S)-2-(beta-D-Glucopyranosyloxy)-5-(methoxycarbonyl)-3-vinyl-3,4-dihydro-2H-pyran-4-yl]acetic acid) | C17H24O11 | 58822-47-2 | Details |
| Selamectin (350 mg) | C43H63NO11 | 220119-17-5 | Details |
| Selegiline Hydrochloride (200 mg) | C13H18ClN | 14611-52-0 | Details |
| Selegiline Related Compound D (15 mg) ((R)-N-(1-Phenylpropan-2-yl)prop-2-yn-1-amine hydrochloride) | C12H15NHCl | 115586-38-4 | Details |
| Selenomethionine (100 mg) | C5H11NO2Se | 3211-76-5 | Details |
| Sesame Oil (1 g) | 8008-74-0 | Details |
| Product Total： Product Page： | ||||
| 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 | ||||